Tasosartan

CAS No. 145733-36-4

Tasosartan( WAY-ANA 756 )

Catalog No. M21071 CAS No. 145733-36-4

Tasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 67 Get Quote
5MG 110 Get Quote
10MG 177 Get Quote
25MG 300 Get Quote
50MG 447 Get Quote
100MG 624 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Tasosartan
  • Note
    Research use only, not for human use.
  • Brief Description
    Tasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
  • Description
    Tasosartan is an antagonist of angiotensin II type 2 (AT2) receptor (IC50 = 1.2 nM).
  • In Vitro
    Tasosartan is an orally active nonpeptide AngII antagonist that has demonstrates specific and selective AT1 receptor antagonistic activity in vitro.IC50 for inhibition of specific binding of 125I-AngII to rat adrenal membrane in the absence of proteins in binding buffer is 1.2±0.6 nM.
  • In Vivo
    Administration of Tasosartan at doses of 1.0 and 3.0 mg/kg (iv) significantly (p<0.05) attenuates the pressor response to angiotensin-II in rats.
  • Synonyms
    WAY-ANA 756
  • Pathway
    Endocrinology/Hormones
  • Target
    RAAS
  • Recptor
    AT2 receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    145733-36-4
  • Formula Weight
    411.46
  • Molecular Formula
    C23H21N7O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (303.80 mM)
  • SMILES
    Cc1nc(C)c2c(n1)N(Cc1ccc(-c3ccccc3-c3nn[nH]n3)cc1)C(=O)CC2
  • Chemical Name
    8-((2'-(1H-tetrazol-5-yl)-[11'-biphenyl]-4-yl)methyl)-24-dimethyl-58-dihydropyrido[23-d]pyrimidin-7(6H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Maillard M P Rossat J Brunner H R et al. Tasosartan enoltasosartan and angiotensin II receptor blockade: The confounding role of protein binding[J]. Journal of Pharmacology & Experimental Therapeutics 2000 295(2):649-654.
molnova catalog
related products
  • Breviscapin

    Breviscapine is the total flavonoid components (the content of scutellarin > or =85%) extracted from the dried whole plant of Erigeron breviscapus.

  • Ramiprilat

    Ramiprilat is an angiotensin-converting enzyme (ACE) inhibitor?with antihypertensive activity.

  • ANGIOTENSIN IV TFA

    ANGIOTENSIN IV TFA is a less effective agonist at the angiotensin AT1 receptor.